Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Thirty-two subjects diagnosed with COPD were enrolled, received each study treatment and
completed the follow-up assessments. During each of the four study periods, subjects were
admitted to the clinic on Day -1 and housed overnight until after the last spirometry
measurement. Serial pulmonary function tests were performed and PK (pharmacokinetics) samples
collected up to 25 hours. Subjects were discharged from the clinic on Day 2 after
evaluations.